# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-166004
Filing Date
2017-05-10
Accepted
2017-05-10 16:43:01
Documents
63
Period of Report
2017-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | d377332d10q.htm | 10-Q | 595557
2 | EX-31 | d377332dex31.htm | EX-31 | 6624
3 | EX-32 | d377332dex32.htm | EX-32 | 4568
| Complete submission text file | 0001193125-17-166004.txt |  | 4504526

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE DOCUMENT | mnkd-20170331.xml | EX-101.INS | 632703
5 | XBRL TAXONOMY EXTENSION SCHEMA | mnkd-20170331.xsd | EX-101.SCH | 59311
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | mnkd-20170331_cal.xml | EX-101.CAL | 67477
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mnkd-20170331_def.xml | EX-101.DEF | 366511
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mnkd-20170331_lab.xml | EX-101.LAB | 482188
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mnkd-20170331_pre.xml | EX-101.PRE | 420768

Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 17831081
SIC: 2834 Pharmaceutical Preparations